Renovaro Biosciences Inc. (RENB)
0.81
-0.01 (-0.75%)
At close: Jan 15, 2025, 1:34 PM
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY12 | FY11 |
| Net Income | -80.65M | -39.68M | -113.43M | -26.72M | -11.42M | -18.02M | -6.31M | -2.14M | -1.74M | -2.37M | -37.59K | -29.95K |
| Depreciation & Amortization | 121.86K | 113.50K | 123.59K | 123.53K | 366.27K | 71.71K | 18.48K | 14.53K | 27.39K | 45.20K | n/a | n/a |
| Stock-Based Compensation | 4.67M | 3.54M | 5.49M | 1.44M | 1.03M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Working Capital | 4.75M | 410.16K | 332.21K | 1.20M | -175.59K | 109.00K | -311.04K | 127.18K | -78.48K | -101.32K | 7.50K | n/a |
| Other Non-Cash Items | 56.07M | 995.80K | -2.60M | 3.34M | -200.59K | 9.29M | 1.85M | 1.21M | -254.54K | n/a | n/a | 5.00K |
| Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Change in Working Capital | 8.81M | 4.31M | 1.42M | 1.20M | -97.47K | 198.88K | -83.46K | -53.96K | 233.20K | 291.51K | 7.50K | n/a |
| Operating Cash Flow | -10.97M | -11.77M | -15.73M | -20.61M | -10.46M | -8.51M | -4.34M | -1.18M | -1.47M | -2.03M | -30.09K | -24.95K |
| Capital Expenditures | -70.43K | -29.77K | -5.16K | -48.89K | -184.46K | -716.67K | -30.00K | n/a | n/a | n/a | n/a | n/a |
| Acquisitions | 65.85K | n/a | n/a | n/a | n/a | n/a | -294.93K | n/a | n/a | n/a | n/a | n/a |
| Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Investing Acitivies | -1.26M | n/a | n/a | n/a | n/a | n/a | -250.80K | -196.14K | n/a | -1.95M | n/a | -13.22K |
| Investing Cash Flow | -1.26M | -29.77K | -5.16K | -48.89K | -184.46K | -716.67K | -575.73K | -196.14K | n/a | -1.95M | n/a | -13.22K |
| Debt Repayment | 7.18M | -1.12M | -560.85K | -546.65K | 6.20M | n/a | n/a | 2.00M | n/a | -617.92K | 36.50K | 13.50K |
| Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | 341.87K | 1.63M | 134.91K | 82.06K | 1.00M | 6.02M | n/a | n/a | n/a | -89.36K | n/a | n/a |
| Financial Cash Flow | 10.52M | 4.52M | 4.25M | 32.60M | 7.20M | 6.02M | 16.71M | 5.51M | n/a | 6.67M | 36.50K | 38.50K |
| Net Cash Flow | -1.65M | -7.30M | -11.49M | 11.97M | -3.59M | -3.32M | 11.66M | 3.92M | -1.47M | 2.99M | 6.41K | 336.00 |
| Free Cash Flow | -11.04M | -11.80M | -15.74M | -20.66M | -10.64M | -9.22M | -4.37M | -1.18M | -1.47M | -2.03M | -30.09K | -24.95K |